Save Up To 70% with generic medications and up to 40% with brand name drugs. Get FREE WorldWide shipping on $149 or more...
Infectious... » NexMed Announces Decision For...
Home » News » NexMed Announces Decision For Anti-Fungal...
NexMed Announces Decision For Anti-Fungal Product
NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® technology, announced the mutual decision with Novartis to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus.
Read full article @ MedicalNewsToday
Read Also Other "Infectious Diseases / Bacteria / Viruses" News
-
Also In Global Health News: Sri Lanka's IDPs; Zimbabwe Doctor Strike; Nigerian HIV Marriages; Tracking Disease In India
Heavy Rains Worsen Health Conditions For IDPs In Sri Lanka...
-
Bacterial Communication: Finding The Constant
The Rosetta Stone of bacterial communication may have been found. Although...
-
Cal/OSHA Standards Become First In The Nation Protections Against Infectious Airborne Diseases
The nation's first standard to safeguard workers from the spread of airborne...
